Can Eye-Tracking reveal hidden brain risks in babies with sickle cell disease?
NCT ID NCT07721155
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
Sickle cell disease can affect brain development even in very young children. This study uses eye-tracking—a simple, non-invasive method—to measure attention and processing speed in infants aged 6 to 24 months. The goal is to identify those at highest risk for cognitive challenges early, so that supportive interventions can be started sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could enable early detection of cognitive problems in children with sickle cell disease, allowing for timely interventions to support brain development.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly improve outcomes, and eye-tracking may not fully capture complex cognitive abilities.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROCOGNITION, CHILD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam UMC
Amsterdam, 1105AZ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple screening test at birth save thousands of children with sickle cell disease?
- Can a peer coach help young people take control of their chronic illness?
- Could a stronger dose of an old drug protect children with sickle cell from organ damage?
- Gene editing could cure sickle cell by boosting fetal hemoglobin
- New stem cell processing method offers hope for patients without a perfect donor match
- Milder stem cell transplant could tame aggressive sickle cell disease